MM promoted KSR2 binding to oncogenic BRAF and enhanced ERK pathway
MM promoted KSR2 binding to oncogenic BRAF and enhanced ERK pathway activation, even though a larger dose (11 mM) did not induce heterodimerization on the two proteins. Hence, it appeared…